Appeals Courts Vacate Half a Billion in Verdicts Against Johnson & Johnson

Johnson & Johnson (J&J) has successfully challenged two talc verdicts and has mitigated nearly $500 million in damages in less than a week. The largest verdict to date, the $417 million  Echevarria verdict, was reversed and a new trial has been ordered. This decision comes at the heels of J&J convincing a St. Louis appeals court to vacate a separate $72 million verdict. Superior Court Judge Maren Nelson concluded that the evidence presented during Echevaria’s trial didn’t support the large verdict.  Judge Nelson wrote that…
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

This Week’s Life Science Headlines

        Litigation
Continue reading...

Johnson & Johnson Settles Hip Implant Case Two Weeks Before Trial

Last week, Johnson and Johnson settled a bellweather case that was scheduled to commence on October 15, 2013 in California.  Plaintiff in that action claimed that his injuries were allegedly caused by the company’s ASR metal-on-metal hip implants.  The case is Ottman v. Johnson & Johnson, No. CGC-12-517391, in California Superior Court. The terms of the settlement are confidential. Another bellweather trial involving the company’s hip implants is scheduled to take place in early 2014 in Los Angeles. Johnson & Johnson and its subsidiary DePuy…
Continue reading...